Discontinued — last reported Q2 '24

Other

Accrued sales commissions

STERIS Accrued sales commissions increased by 1.2% to $33.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.6%, from $34.71M to $33.80M. Over 4 years (FY 2021 to FY 2025), Accrued sales commissions shows an upward trend with a 4.1% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ3 2018
Last reportedQ2 2024
Metric ID: other_accrued_sales_commission_current_and_noncurrent

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$31.85M$33.30M$37.04M$31.70M$34.45M$36.41M$32.30M$31.10M$34.00M$35.10M$36.39M$33.28M$32.93M$34.06M$34.71M$32.10M$32.80M$33.40M$33.80M
QoQ Change+4.5%+11.2%-14.4%+8.7%+5.7%-11.3%-3.7%+9.3%+3.2%+3.7%-8.5%-1.0%+3.4%+1.9%-7.5%+2.2%+1.8%+1.2%
YoY Change+8.2%+9.3%-12.8%-1.9%-1.3%-3.6%+12.7%+7.0%-3.1%-2.9%-4.6%-3.5%-0.4%-1.9%-2.6%
Range$31.10M$37.04M
CAGR+1.3%
Avg YoY Growth-0.1%
Median YoY Growth-1.9%
Current Streak3 quarters growth

Frequently Asked Questions

What is STERIS's accrued sales commissions?
STERIS (STE) reported accrued sales commissions of $33.80M in Q4 2025.
How has STERIS's accrued sales commissions changed year-over-year?
STERIS's accrued sales commissions decreased by 2.6% year-over-year, from $34.71M to $33.80M.
What is the long-term trend for STERIS's accrued sales commissions?
Over 4 years (2021 to 2025), STERIS's accrued sales commissions has grown at a 4.1% compound annual growth rate (CAGR), from $27.35M to $32.10M.